Works by Mann, Philipp

Results: 17
    1

    Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials.

    Published in:
    PLoS Medicine, 2020, v. 17, n. 5, p. 1, doi. 10.1371/journal.pmed.1003117
    By:
    • Moodie, Zoe;
    • Walsh, Stephen R.;
    • Laher, Fatima;
    • Maganga, Lucas;
    • Herce, Michael E.;
    • Naidoo, Sarita;
    • Hosseinipour, Mina C.;
    • Innes, Craig;
    • Bekker, Linda-Gail;
    • Grunenberg, Nicole;
    • Mann, Philipp;
    • Yu, Chenchen;
    • deCamp, Allan C.;
    • Miner, Maurine D.;
    • Yates, Nicole L.;
    • Heptinstall, Jack;
    • Mkhize, Nonhlanhla N.;
    • Dintwe, One;
    • Frahm, Nicole;
    • Cohen, Kristen W.
    Publication type:
    Article
    2

    Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials.

    Published in:
    2020
    By:
    • Moodie, Zoe;
    • Walsh, Stephen R;
    • Laher, Fatima;
    • Maganga, Lucas;
    • Herce, Michael E;
    • Naidoo, Sarita;
    • Hosseinipour, Mina C;
    • Innes, Craig;
    • Bekker, Linda-Gail;
    • Grunenberg, Nicole;
    • Mann, Philipp;
    • Yu, Chenchen;
    • deCamp, Allan C;
    • Miner, Maurine D;
    • Yates, Nicole L;
    • Heptinstall, Jack;
    • Mkhize, Nonhlanhla N;
    • Dintwe, One;
    • Frahm, Nicole;
    • Cohen, Kristen W
    Publication type:
    journal article
    3

    Safety and Immunogenicity of PENNVAX-G DNA Prime Administered by Biojector 2000 or CELLECTRA Electroporation Device With Modified Vaccinia Ankara-CMDR Boost.

    Published in:
    2017
    By:
    • Ake, Julie A.;
    • Schuetz, Alexandra;
    • Pegu, Poonam;
    • Wieczorek, Lindsay;
    • Eller, Michael A.;
    • Kibuuka, Hannah;
    • Sawe, Fredrick;
    • Maboko, Leonard;
    • Polonis, Victoria;
    • Karasavva, Nicos;
    • Weiner, David;
    • Sekiziyivu, Arthur;
    • Kosgei, Josphat;
    • Missanga, Marco;
    • Kroidl, Arne;
    • Mann, Philipp;
    • Ratto-Kim, Silvia;
    • Eller, Leigh Anne;
    • Earl, Patricia;
    • Moss, Bernard
    Publication type:
    journal article
    4
    5

    Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I Trial.

    Published in:
    PLoS ONE, 2016, v. 11, n. 5, p. 1, doi. 10.1371/journal.pone.0155702
    By:
    • Joachim, Agricola;
    • Bauer, Asli;
    • Joseph, Sarah;
    • Geldmacher, Christof;
    • Munseri, Patricia J.;
    • Aboud, Said;
    • Missanga, Marco;
    • Mann, Philipp;
    • Wahren, Britta;
    • Ferrari, Guido;
    • Polonis, Victoria R.;
    • Robb, Merlin L.;
    • Weber, Jonathan;
    • Tatoud, Roger;
    • Maboko, Leonard;
    • Hoelscher, Michael;
    • Lyamuya, Eligius F.;
    • Biberfeld, Gunnel;
    • Sandström, Eric;
    • Kroidl, Arne
    Publication type:
    Article
    6

    Safety and Immunogenicity of Ad26-vectored HIV Vaccine with Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-uninfected Adults: A Phase 1/2a Study.

    Published in:
    2023
    By:
    • Stieh, Daniel J;
    • Barouch, Dan H;
    • Comeaux, Christy;
    • Sarnecki, Michal;
    • Stephenson, Kathryn E;
    • Walsh, Stephen R;
    • Sawant, Sheetal;
    • Heptinstall, Jack;
    • Tomaras, Georgia D;
    • Kublin, James G;
    • McElrath, M Juliana;
    • Cohen, Kristen W;
    • Rosa, Stephen C De;
    • Alter, Galit;
    • Ferrari, Guido;
    • Montefiori, David;
    • Mann, Philipp;
    • Nijs, Steven;
    • Callewaert, Katleen;
    • Goepfert, Paul A
    Publication type:
    journal article
    7

    Optimizing the immunogenicity of HIV prime-boost DNA-MVA-rgp140/GLA vaccines in a phase II randomized factorial trial design.

    Published in:
    PLoS ONE, 2018, v. 13, n. 11, p. 1, doi. 10.1371/journal.pone.0206838
    By:
    • Viegas, Edna O.;
    • Kroidl, Arne;
    • Munseri, Patricia J.;
    • Missanga, Marco;
    • Nilsson, Charlotta;
    • Tembe, Nelson;
    • Bauer, Asli;
    • Joachim, Agricola;
    • Joseph, Sarah;
    • Mann, Philipp;
    • Geldmacher, Christof;
    • Fleck, Sue;
    • Stöhr, Wolfgang;
    • Scarlatti, Gabriella;
    • Aboud, Said;
    • Bakari, Muhammad;
    • Maboko, Leonard;
    • Hoelscher, Michael;
    • Wahren, Britta;
    • Robb, Merlin L.
    Publication type:
    Article
    8

    Investigation of the halo-artifact in <sup>68</sup>Ga-PSMA-11-PET/MRI.

    Published in:
    PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0183329
    By:
    • Heußer, Thorsten;
    • Mann, Philipp;
    • Rank, Christopher M.;
    • Schäfer, Martin;
    • Dimitrakopoulou-Strauss, Antonia;
    • Schlemmer, Heinz-Peter;
    • Hadaschik, Boris A.;
    • Kopka, Klaus;
    • Bachert, Peter;
    • Kachelrieß, Marc;
    • Freitag, Martin T.
    Publication type:
    Article
    9

    Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2: A phase 1 randomized clinical trial.

    Published in:
    Wiener Klinische Wochenschrift, 2021, v. 133, n. 17/18, p. 931, doi. 10.1007/s00508-021-01922-y
    By:
    • Kremsner, Peter G.;
    • Mann, Philipp;
    • Kroidl, Arne;
    • Leroux-Roels, Isabel;
    • Schindler, Christoph;
    • Gabor, Julian J.;
    • Schunk, Mirjam;
    • Leroux-Roels, Geert;
    • Bosch, Jacobus J.;
    • Fendel, Rolf;
    • Kreidenweiss, Andrea;
    • Velavan, Thirumalaisamy P.;
    • Fotin-Mleczek, Mariola;
    • Mueller, Stefan O.;
    • Quintini, Gianluca;
    • Schönborn‑Kellenberger, Oliver;
    • Vahrenhorst, Dominik;
    • Verstraeten, Thomas;
    • Alves de Mesquita, Margarida;
    • Walz, Lisa
    Publication type:
    Article
    10
    11
    12
    13

    Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein.

    Published in:
    Clinical Infectious Diseases, 2021, v. 72, n. 1, p. 50, doi. 10.1093/cid/ciz1239
    By:
    • Hosseinipour, Mina C;
    • Innes, Craig;
    • Naidoo, Sarita;
    • Mann, Philipp;
    • Hutter, Julia;
    • Ramjee, Gita;
    • Sebe, Modulakgotla;
    • Maganga, Lucas;
    • Herce, Michael E;
    • deCamp, Allan C;
    • Marshall, Kyle;
    • Dintwe, One;
    • Andersen-Nissen, Erica;
    • Tomaras, Georgia D;
    • Mkhize, Nonhlanhla;
    • Morris, Lynn;
    • Jensen, Ryan;
    • Miner, Maurine D;
    • Pantaleo, Giuseppe;
    • Ding, Song
    Publication type:
    Article
    14

    Priming with a Simplified Intradermal HIV-1 DNA Vaccine Regimen followed by Boosting with Recombinant HIV-1 MVA Vaccine Is Safe and Immunogenic: A Phase IIa Randomized Clinical Trial.

    Published in:
    PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0119629
    By:
    • Munseri, Patricia. J.;
    • Kroidl, Arne;
    • Nilsson, Charlotta;
    • Joachim, Agricola;
    • Geldmacher, Christof;
    • Mann, Philipp;
    • Moshiro, Candida;
    • Aboud, Said;
    • Lyamuya, Eligius;
    • Maboko, Leonard;
    • Missanga, Marco;
    • Kaluwa, Bahati;
    • Mfinanga, Sayoki;
    • Podola, Lilly;
    • Bauer, Asli;
    • Godoy-Ramirez, Karina;
    • Marovich, Mary;
    • Moss, Bernard;
    • Hoelscher, Michael;
    • Gotch, Frances
    Publication type:
    Article
    15

    Innate Responses to the Former COVID-19 Vaccine Candidate CVnCoV and Their Relation to Reactogenicity and Adaptive Immunogenicity.

    Published in:
    Vaccines, 2024, v. 12, n. 4, p. 388, doi. 10.3390/vaccines12040388
    By:
    • Wolz, Olaf-Oliver;
    • Vahrenhorst, Dominik;
    • Quintini, Gianluca;
    • Lemberg, Christina;
    • Koch, Sven D.;
    • Kays, Sarah-Katharina;
    • Walz, Lisa;
    • Kulkarni, Neeraja;
    • Fehlings, Michael;
    • Wengenmayer, Peter;
    • Heß, Jana;
    • Oostvogels, Lidia;
    • Lazzaro, Sandra;
    • von Eisenhart-Rothe, Philipp;
    • Mann, Philipp
    Publication type:
    Article
    16
    17